(Q43464859)

23 November 2017

title

Octreotide reduces hepatic, renal and breast cystic volume in autosomal-dominant polycystic kidney disease (English)

1 reference

autosomal dominant polycystic kidney disease

23 November 2017

main subject

0 references

author name string

Ramón Peces

1

1 reference

23 November 2017

Emilio Cuesta-López

2

1 reference

23 November 2017

Carlos Peces

3

1 reference

23 November 2017

Virginia Pérez-Dueñas

4

1 reference

23 November 2017

Cristina Vega-Cabrera

5

1 reference

23 November 2017

Rafael Selgas

6

1 reference

23 November 2017

publication date

7 May 2010

1 reference

International Urology and Nephrology

23 November 2017

published in

1 reference

23 November 2017

volume

43

1 reference

23 November 2017

issue

2

1 reference

23 November 2017

page(s)

565-569

1 reference

Outcomes of sonography-based management of breast cysts

23 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11255-010-9748-1

Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3',5'-cyclic monophosphate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-010-9748-1

Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-010-9748-1

Lanreotide reduces the volume of polycystic liver: a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-010-9748-1

Increases in kidney volume in autosomal dominant polycystic kidney disease can be detected within 6 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-010-9748-1

Somatostatin analogues reduce liver volume in polycystic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-010-9748-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-010-9748-1

Sirolimus reduces polycystic liver volume in ADPKD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-010-9748-1

Intraluminal autocrine purinergic signaling within cysts: implications for the progression of diseases that involve encapsulated cyst formation

21 January 2018

1 reference

12 December 2020

Cystic changes of breast in a family with autosomal dominant polycystic kidney disease

1 reference

12 December 2020

Rapamycin reduces kidney volume and delays the loss of renal function in a patient with autosomal-dominant polycystic kidney disease

1 reference

12 December 2020

Kidney and breast cysts: a comparative study of fluids

1 reference

12 December 2020

Volume progression in polycystic kidney disease

1 reference

12 December 2020

Adult polycystic kidney disease: a disorder of connective tissue?

1 reference

12 December 2020

10.1007/S11255-010-9748-1

Identifiers

DOI

1 reference

23 November 2017

1 reference